C4 Therapeutics (CCCC) Other Non Operating Income (2019 - 2023)

C4 Therapeutics has reported Other Non Operating Income for 3 years, with the latest figure at -$621000.0 in Q3 2023.

• For the quarter ending Q3 2023, Other Non Operating Income changed N/A year-over-year to -$621000.0; the trailing twelve-month figure through Dec 2024 stood at -$621000.0 (changed 0.0% YoY), and the FY2023 full-year result was -$621000.0, changed N/A from the prior year.
• Other Non Operating Income for Q3 2023 stood at -$621000.0, down from $43000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $43000.0 in Q3 2020, with the low at -$621000.0 in Q3 2023.
• Average Other Non Operating Income over 3 years is -$193000.0, with a median of -$1000.0 recorded in 2019.
• Peak annual rise in Other Non Operating Income reached 4400.0% in 2020, while the deepest fall reached 4400.0% in 2020.
• Tracing CCCC's Other Non Operating Income over 3 years: stood at -$1000.0 in 2019, then soared by 4400.0% to $43000.0 in 2020, then slumped by 1544.19% to -$621000.0 in 2023.
• The last three Other Non Operating Income figures came in at -$621000.0 (Q3 2023), $43000.0 (Q3 2020), and -$1000.0 (Q3 2019), per Business Quant data.

Peer Comparison